D-0353-2021 Class II Ongoing
FDA drug recall D-0353-2021 was initiated by Na Na Collection on Mar 30, 2021 and is designated Class II. Reason for recall: Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and/or sildenafil. The recall status is ongoing.
Recall details
- Product Type
- Drugs
- Report Date
- May 5, 2021
- Initiation Date
- Mar 30, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
PremierZen Platinum 5000, Packaged in paper packaging with a pill blister, 1 capsule per box, Distributed by New Premier Group Los Angeles CA 90006
Reason for recall
Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and/or sildenafil.
Distribution pattern
Nationwide with the United States
Code information
Lot #: GATCO 01671, Exp Date 12/30/2024 Serial # 728175421856
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0353-2021
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026